Calendar

Pre-event estimates show a marginally positive 30-day EPS revision, but revenue upside and the required recent price/volume setup were not established; the thin evidence does not support an investable surprise screen entry.

Acuity's prior-quarter results beat EPS and revenue estimates, but the available preview reported flat 30-day EPS estimates and no qualifying price/volume or revision evidence.

Nike's pre-event outlook showed falling expected EPS and revenue, alongside substantial share-price weakness and brand/competitive concerns; no positive revision or upside catalyst offset those headwinds, and tape confirmation is incomplete.

The supplied calendar identifies AEHR for the window, but the checked searches did not establish credible pre-event EPS and revenue consensus/revision data or the required tape and risk signals.

McCormick's pre-event preview pointed to revenue growth and possible sequential volume improvement, but EPS estimates were unchanged and expected to decline; price/volume criteria were not verified.

RPM's prior-quarter result modestly beat estimates, but checked material did not establish current positive estimate revisions, revenue upside, or the required pre-event price/volume signals.

Lamb Weston's last three reported quarters beat EPS estimates and the latest quarter beat revenue estimates, but no current positive revisions or qualifying tape were verified; historical execution alone is insufficient.

Constellation's earnings date and consensus are supported, but recent analyst action lowered estimates amid a softer consumer backdrop; a positive surprise signal and qualifying tape were not established.

Penguin has improving alt-data signals and recent AI-related business momentum, but shares were down over three months and checked sources did not establish positive current estimate revisions, revenue upside, or qualifying tape.

Neogen's latest checked fiscal guidance suggested better full-year revenue expectations, but the upcoming quarter consensus is inconsistent across sources and recent EPS results have been weak; tape and positive revisions are absent.

Levi's prior quarters showed EPS and revenue beats, but the checked forward sources gave inconsistent date confirmation and no positive estimate revision or qualifying tape; the calendar confirmation is taken from the supplied context.

Applied Digital has visible AI/data-center demand but recent quarterly EPS missed consensus and the checked forward estimates are negative; financing/capex execution risk and absent tape confirmation keep this outside the qualifying set.

Nurix is a clinical-stage biotechnology company with lumpy collaboration revenue and recent quarterly EPS misses; available date sources conflict, and required tape and risk checks were not established.

6 , 327 Shares in Vanguard High Dividend Yield ETF $VYM Acquired by Cauble & Harre Wealth Management Inc .